abstract |
H:fmt\inteoven\NRPortblDCC\FMTUl5779678_l.doex-3/10/2017 The present invention relates to monoclonal antibodies binding to human lectin-like oxidized LDL (low density lipoprotein) receptor 1 (hereinafter, sometimes referred to as "LOX-1 "), and pharmaceutical compositions and methods of treatment comprising the same. |